ZIMMER BIOMET HOLDINGS, INC. (NYSE:ZBH) Files An 8-K Entry into a Material Definitive AgreementItem 1.01
EXHIBIT INDEX
|
Exhibit No. |
Description |
| 10.1 | Term Loan Agreement ¥21,300,000,000, dated as of September22, 2017, between Zimmer Biomet G.K. and Sumitomo Mitsui Banking Corporation |
| 10.2 | Amended and Restated Term Loan Agreement ¥11,700,000,000, dated as of September22, 2017, between Zimmer Biomet G.K. and Sumitomo Mitsui Banking Corporation |
| 10.3 | Amended and Restated Letter of Guarantee, dated as of September22, 2017, made by Zimmer Biomet Holdings, Inc. in favor of Sumitomo Mitsui Banking Corporation |
ZIMMER BIOMET HOLDINGS, INC. ExhibitEX-10.1 2 d464265dex101.htm EX-10.1 EX-10.1 Exhibit 10.1 TERM LOAN AGREEMENT ¥21,…To view the full exhibit click here
About ZIMMER BIOMET HOLDINGS, INC. (NYSE:ZBH)
Zimmer Biomet Holdings, Inc., formerly Zimmer Holdings, Inc., is engaged designing, manufacturing and marketing orthopaedic reconstructive products; sports medicine, biologics, extremities and trauma products; spine, bone healing, craniomaxillofacial and thoracic products; dental implants, and related surgical products. The Company’s products and solutions helps treat patients suffering from disorders of, or injuries to, bones, joints, or supporting soft tissues. The Company manages its operations through three geographic operating segments: the Americas, consists of the United States and includes other North, Central and South American markets; EMEA, consists of Europe and includes the Middle East and African markets, and Asia Pacific, consists of Japan and includes other Asian and Pacific markets. Its four product category segments include Americas Spine, Bone Healing Craniomaxillofacial and Thoracic, and Dental.